KLHDC2

Kelch domain-containing protein 2 · Q9Y2U9 · KLHDC2 on Sugi Atlas →

0 patent compounds predicted against KLHDC2, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to KLHDC2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer PHASE1/PHASE2COMPLETED
Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer PHASE1/PHASE2UNKNOWN
Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer PHASE1/PHASE2COMPLETED
Combination of Chemoradiation Therapy and Epitope Peptide Vaccine Therapy in Treating Patients With Esophageal Cancer PHASE1UNKNOWN
Tolerability of Enteral NAC in Infants PHASE1NOT_YET_RECRUITING
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal Cancer PHASE1COMPLETED
Role of TLR4 in Environmental Asthma PHASE1COMPLETED
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Gastric Cancer PHASE1COMPLETED
Investigation of the Genetic Causes of Kallmann Syndrome and Reproductive Disorders nanCOMPLETED
A Study of Genetic Influence on LDL Hyper-responsiveness in Patients Following a Ketogenic Diet nanRECRUITING
The Genetics of Environmental Asthma nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Immunogenetics of Visceral Leishmaniasis nanCOMPLETED
PCD New Gene Discovery nanCOMPLETED
Tecfidera Diffusion Tensor Imaging nanCOMPLETED
Genetic Epidemiology of Asthma in Costa Rica nanCOMPLETED
Evaluation of Serum Gasdermin D Level As a Potential Biomarker of Disease Activity in Vitiligo Patients nanUNKNOWN
Autophagy Bladder Cancer nanUNKNOWN
Pharmacogenomics of Interferon and Ribavirin Treatment in Patients With Chronic Hepatitis C Virus Infection nanUNKNOWN
Speech and Short-term Memory Functions in Dyslexia: a Combined MEG and EEG Study nanUNKNOWN
Genetic, Dietary and Environmental Influences on Vitamin D Metabolism nanCOMPLETED
Chromosome 5Q Gene Variants and Asthma-Related Traits nanCOMPLETED
Urinary Kallikrein and Hypertension: A Prospective Study nanCOMPLETED
KLHL14 Expression as Predicting Factor of Invasiveness in pitNET nanCOMPLETED
Gene Expression, Metabolomic, Microbiome, and Calcium Metabolism in Response to Varied Vitamin D Dosages nanCOMPLETED
Effects of Donor and Recipient Genetic Expression on Heart, Lung, Liver, or Kidney Transplant Survival nanCOMPLETED
Diet, Genetics, and CVD Risk Factor Response in Blacks nanCOMPLETED
Risk Burden of Lipoprotein Metabolic Gene Haplotypes nanCOMPLETED
Genetic-specific Effects of Fructose on Liver Lipogenesis nanCOMPLETED
Genetics and Psychopathology in the 22q11 Deletion Syndrome nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a KLHDC2 binder may also engage these)

ProteinNameSimilarity
Q3KRE6 1.000 Q3KRE6 →
Q4G5Y1 1.000 Q4G5Y1 →
Q5E9A7 1.000 Q5E9A7 →
Q80YG3 0.995 Q80YG3 →
Q8N7A1 0.991 Q8N7A1 →
Q28DE7 0.979 Q28DE7 →
Q5U580 0.973 Q5U580 →
Q6PID8 0.971 Q6PID8 →
Q6PAR0 0.968 Q6PAR0 →
Q0IIC2 0.967 Q0IIC2 →
Q5EA50 0.960 Q5EA50 →
A2AAX3 0.959 A2AAX3 →
Q8VCH5 0.959 Q8VCH5 →
Q5U3Y0 0.959 Q5U3Y0 →
Q7Z6M1 0.957 Q7Z6M1 →
Q4V8F4 0.956 Q4V8F4 →
Q5RGB8 0.953 Q5RGB8 →
D3ZA50 0.953 D3ZA50 →
Q6AXB2 0.953 Q6AXB2 →
Q96M94 0.952 Q96M94 →
CHEK1 Serine/threonine-protein kinase Chk1 0.951 landscape →
Q8BRG6 0.950 Q8BRG6 →
Q6TFL4 0.950 Q6TFL4 →
Q6DEL7 0.950 Q6DEL7 →
Q56A24 0.950 Q56A24 →
Q9Y6I7 0.949 Q9Y6I7 →
Q1LYM6 0.949 Q1LYM6 →
O35280 0.948 O35280 →
G3X9X1 0.948 G3X9X1 →
Q5ZJU2 0.947 Q5ZJU2 →